Abstract 9142: Predictors of New-Onset Atrial Fibrillation in the Setting of Acute Coronary Syndromes: A Nationwide Multi-Center Study
Jia Yi Anna Ne,Austin Chin Chwan Ng,HYUN Karice,Farzaneh Boroumand,Clara K Chow,Ben B Freedman,David Brieger,Jia Yi Anna NeAustin Chin Chwan NgKarice HYUNFarzaneh BoroumandClara K ChowBen B FreedmanDavid BriegerCardiology,The Univ of Sydney,Concord Hosp,Westmead Hosp,Concord,AustraliaCardiology,Concord Hosp,AustraliaCardiology,Sch of Health Sciences,Faculty of Medicine and Health,Univ of Sydney,Concord,AustraliaANZAC research Institute,Univ of Sydney,AustraliaUNIVERSITY OF SYDNEY,Westmead,AustraliaHEART RESEARCH INSTITUTE,THE UNIVERSITY OF SYDNEY,Sydney,AustraliaCardiology,Concord Hosp,Sydney,Australia
DOI: https://doi.org/10.1161/circ.144.suppl_1.9142
IF: 37.8
2021-11-10
Circulation
Abstract:Introduction: New-onset atrial fibrillation (AF) following acute myocardial infarction (AMI) is associated with adverse outcomes, though studies exploring the interaction between AF and the full spectrum of acute coronary syndromes (ACS) are scarce. We aim to identify predictors of new-onset AF in the setting of ACS by analyzing data from the prospective CONCORDANCE multi-center registry. Methods: Patients admitted to 41 Australian hospitals from 2009-2018 with ACS and had an angiogram were included. New-onset AF was defined as AF detected on index ECG and/or in-hospital AF. Independent predictors of new-onset AF were identified using multivariable logistic regression models. Results: Of 9070 consecutive patients admitted with ACS, 648 (7.1%) patients developed new-onset AF. These patients had higher rates of major adverse in-hospital events and all-cause mortality compared to patients without new-onset AF. Age (adjusted odds ratio [aOR] 1.04, 95% confidence interval [CI] 1.03-1.05), male sex (aOR 1.62, 95%CI 1.29-2.04), higher admission heart rate (aOR 1.02, 95%CI 1.01-1.02), cardiac arrest on admission (aOR 1.98, 95%CI 1.23-3.20), Killip classes 2 (aOR 1.38, 95%CI 1.10-1.73) and 3/4 (aOR 1.72, 95%CI 1.24-2.40) versus 1 were independent predictors of new-onset AF, whereas hypertension (aOR 0.81, 95%CI 0.67-0.99), higher minimum hemoglobin (aOR 0.98, 95%CI 0.97-0.98), pre-admission statins (aOR 0.71, 95%CI 0.56-0.89) and undergoing PCI (aOR 0.64, 95%CI 0.53-0.77) were associated with decreased risk of new-onset AF. When angiographic disease burden was included, double and triple-vessel disease were independent predictors of new-onset AF. However, sequential addition of CABG to the model nullified this association; (CABG (aOR 3.94, 95%CI 2.83-5.49), disease burden non-significant). In the CABG subgroup, peripheral arterial disease (aOR 1.98, 95%CI 1.20-3.27) was an independent predictor of new-onset AF (all p<0.05). Conclusions: This present study identified patients at risk of new-onset AF in the setting of ACS. Such patients could be targeted for increased surveillance for AF and related adverse outcomes during the post-infarct period. In addition, future studies should explore strategies to prevent new-onset AF after ACS.
cardiac & cardiovascular systems,peripheral vascular disease